|
1
|
Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
|
Am J Kidney Dis
|
2009
|
1.20
|
|
2
|
A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-κB and generating reactive oxygen species.
|
Int J Cancer
|
2011
|
0.91
|
|
3
|
A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFkappaB and generating reactive oxygen species.
|
Prostate
|
2010
|
0.88
|
|
4
|
Nuclear factor-kappaB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemia.
|
Br J Haematol
|
2008
|
0.88
|
|
5
|
Going beyond the kidney disease outcomes quality initiative: hemodialysis access experience at Kaiser Permanente Southern California.
|
Ann Vasc Surg
|
2006
|
0.81
|
|
6
|
Inhibition of NF-κB and DNA double-strand break repair by DMAPT sensitizes non-small-cell lung cancers to X-rays.
|
Free Radic Biol Med
|
2011
|
0.81
|
|
7
|
Polyamine modulation of NMDARs as a mechanism to reduce effects of alcohol dependence.
|
Recent Pat CNS Drug Discov
|
2012
|
0.78
|
|
8
|
Smoking risk and the likelihood of quitting among African-American female light and heavy smokers.
|
J Natl Med Assoc
|
2008
|
0.78
|
|
9
|
Management of patients with chronic kidney disease at Kaiser Permanente.
|
Nephrol News Issues
|
2003
|
0.78
|
|
10
|
Managing high-risk, high-cost patients: the southern california kaiser permanente experience in the medicare ESRD demonstration project.
|
Perm J
|
2005
|
0.75
|
|
11
|
Vascular access management: ongoing challenges and strategies for success.
|
Nephrol News Issues
|
2014
|
0.75
|